基因
GPS2
细胞生物学
分泌物
生物
系统1
AKT1S1
LRP1B型
化学
SOCS6系列
热休克蛋白A9
基因表达
快照23
遗传学
基因表达调控
分泌蛋白
视网膜母细胞瘤样蛋白1
计算生物学
转染
HEK 293细胞
突变
遗传增强
DDB1型
生物信息学
蛋白质-蛋白质相互作用
信号转导
HSP2
肽序列
分子生物学
作者
Ting Gao,Shichao Li,Yuxuan Fan,Wenyi Yan,Minghui He,Qihao Zhang,Yilin Li,Qi Liu,Pengli Wang,Jian Dong Jiang,Lihang Zhang,Yuting Zhou,Liuqi Zhao,Qiqi Xiong,Yuhang Wu,Sichen Yuan,Shaocong Fang,Hongyun Tang,Martin Fussenegger,Hui Wang
标识
DOI:10.1038/s41467-026-76203-1
摘要
On-demand regulation of therapeutic activities is critical to broaden the clinical utility of gene therapies. Here, we employ an Endoplasmic Reticulum-Associated Degradation (ERAD)-centered strategy to develop trigger-inducible gene switches tailor-designed for rapid protein secretion. By temporarily attaching conditional degron motifs to various therapeutic proteins of interest (POIs), inducible, tunable and reversible control of native POI secretion into the bloodstream was achieved through oral administration of specific clinically licensed small-molecule drugs. This simple and generalizable design principle is highly compatible with adeno-associated virus (AAV)-mediated gene delivery, enabling long-term and remote-controlled transgene expression in male mice in vivo. To showcase potential therapeutic benefits of ERAD-level gene switches, we describe gene therapy approaches for cardiovascular diseases and chronic pain - two classes of disease treatments that may most urgently require on-demand drug actions. This study achieves dose- and time-dependent control of transgene activities without requiring the design of overly complex gene circuits, and may form important basis to move synthetic biology-based regulation systems towards therapeutic usage. On-demand regulation of therapeutic activities is critical to broaden the clinical utility of gene therapies. Here the authors develop an endoplasmic reticulum-associated degradation (ERAD)-centred gene switch for therapeutic protein secretion to treat cardiovascular disease and chronic pain.
科研通智能强力驱动
Strongly Powered by AbleSci AI